Peter Opriessnig1, Gunter Almer1, Harald Froehlich1, Claudia Cabella2, Rudolf Stollberger3, Seth Hallstroem4, Gerd Hoerl4, and Harald Mangge1
1Clinical Institute for Medical and Chemical Laboratory Diagnosis, Medical University of Graz, Graz, Austria, 2CRB Bracco Imaging SpA, Colleretto Giacosa, Torino, Italy, 3Institute of Medical Engineering, Graz University of Technology, Graz, Austria, 4Institute of Physiological Chemistry, Medical University of Graz, Graz, Austria
Synopsis
Endothelial
dysfunction plays a key role in the progression and pathogenesis of atherosclerosis (AS).
DCE-MRI in combination with a special nitric oxide donor S-nitroso human serum
albumin (S-NO-HAS) blood pool agent (B22956/1) compound could be an additional
measure that provides information on the influence of plaque burden on the vascular
permeability and vasomotion. In this work, we demonstrate the feasibility to
investigate endothelial barrier function and NO induced endothelium-independent
vasomotor response of the abdominal aorta in control and AS induced rabbits
simultaneously. Relative vessel wall signal enhancement and change in lumen
area were measured using a double-inversion-recovery turbo-spin-echo sequence.Purpose
As an early event, endothelial dysfunction is involved
in the progression of atherosclerosis (AS). Gadolinium based blood pool agents
were successfully applied in the past for fibrous plaque detection and to gain
insight into the leakiness of the endothelial layer via the altered vascular
permeability and albumin as vehicle into the lesion.1,2
In this work we set out to measure the endothelial
barrier function of atherosclerotic rabbits using B-22956/1 an albumin binding
agent in combination with NO donor S-nitroso human serum albumin (S-NO-HSA) and
DCE-MRI. Furthermore, we tested whether the long-term S-NO-HSA-B22956/1 infusion
led to a NO induced vasodilation effect.
Methods
B22956/1: Gadocoletic acid trisodium salt (Bracco Imaging SpA) is
an intravascular high affinity serum albumin binding blood pool agent already
applied to image neovessel- and macrophage- density in atherosclerotic rabbits.3
S-nitroso human serum
albumin: A nitric oxide donor used for NO supplementation
shown to prevent endothelial NO synthase (eNOS) uncoupling in rabbits.4
Animal model: A total of three male New Zealand White (NZW) rabbits
(age:10-11months; body weight:3,5-4,5kg) were used repeatedly in this study. Abdominal
aortic atherosclerosis was induced in two rabbits by a combination of balloon
catheter denudation and a two month high cholesterol diet.
The injury was performed from the iliac bifurcation to the renal artery bifurcation
introducing a 4F wedge pressure balloon catheter through the carotid artery. One
non-treated rabbit fed a normal chow diet was used as control.
S-NO-HSA(-B22956/1) infusion
strategy: Either 18,5mL
of B22956/1(2mM) pre-incubated with S-NO-HSA(1mM)
or B22956/1(2mM) diluted in sodium
chloride were administered intravenously during DCE-MRI. A slow infusion
rate of 20mL/h was chosen for all experiments to prevent uncontrolled NO mediated
hypotension. To assure contrast agent wash out from the vessel wall, experiments
were separated by a whole week. For the injured rabbits the experiments were
repeated two-to-three times ending up in a total of five-to-six imaging sessions.
Imaging: A dark blood double inversion recovery (DIR) T1-weighted
turbo spin echo (T1w-TSE) sequence was used on one selected axial slice for DCE
measurements. Scan parameter were TR/TE:600/12ms; NEX/ETL:4/7; matrix:256x176;
FOV:120x82,5mm; resolution:0.46x0.46x3mm. To avoid chemical shift artifacts
caused by peri-adventitial fat, a spectral fat saturation pulse was applied. A total
of 60 images were acquired with a temporal resolution of 1min1sec. Before long-term
infusion a total of five precontrast images were taken for baseline signal
averaging. All experiments were performed on a human 3Tesla platform (Siemens Magnetom
Prisma) using a 15Ch TxRx knee coil.
Data analysis: Inner and outer vessel wall boundaries of DCE images were
manually segmented using ITK-SNAP. To uncover possible NO mediated wall relaxation
effects boundaries were used to calculate lumen areas over time. Average vessel
wall signal intensities (SI) were calculated for each DCE time
point. In addition, the normalized wall index (NWI=wall area/total vessel area)
was calculated as a measure of wall thickening. The relative signal enhancement c(t) was calculated
by subtracting the signal intensity SI(t) at a given time point from the baseline
tissue signal intensity SI(0) according to equation5: c(t)=(SI(0)-SI(t))/SI(0).
Results
Figure 1 shows the relative vessel wall signal
enhancement c(t) during the long-term infusion of S-NO-HSA-B22956/1 (green line) and B22956/1 (blue line),
respectively. The relative change in lumen area is outlined in Figure 2. A representative
T
1w image together with the NWI is illustrated in Figure 3. Given that a
delayed wall enhancement (decreased vascular permeability) and vasodilation of
the NO donor carrying compound can be observed, a regulation of the endothelial
barrier function as well as an NO induced endothelium-independent vasomotor response
of the control (CTRL) rabbits’ vessel is assumable. For the balloon treated NZW
I (BT-NZW I) no differences in wall enhancement but an NO triggered relaxation
of the artery can be observed, indicating that a vascular damage with endothelial
dysfunction but existing vasorelaxation of smooth muscle cells is assumable. BT-NZW
II with a prominent thickening of the wall (NWI=0.56) shows a reconstituted
delayed endothelial function and contraction of the artery, assuming advanced
plaque burden with possible endothelial regrowth and paradoxical NO induced vasoconstriction.
Discussion and
Conclusion
In this work, we demonstrate for the first time the
feasibility to investigate vascular permeability and NO induced endothelium-independent
vasomotor response of the abdominal aorta in control and balloon denuded
rabbits simultaneously. The role of NO in controlling the interendothelial
junctions and therefore to regulate the endothelial barrier is discussed quite
controversial in literature but our data assume specific patterns depending on
the degree of plaque burden. Future work will investigate the influence of
plaque progression on endothelial barrier regulation and vasomotion which may
help to predict the formation of atherosclerotic plaques.
Acknowledgements
Supported by European Union's FP7 funded Project NanoAthero (grant agreement no 309820).References
1. Meding J, Urich M, Licha K, et al. Magnetic resonance
imaging of atherosclerosis by targeting extracellular matrix deposition with
Gadofluorine M. Contrast Media Mol Imaging. 2007;2(3):120-129. 2. Phinikaridou A, Andia ME, Protti A,
et al. Noninvasive magnetic resonance imaging evaluation of endothelial
permeability in murine atherosclerosis using an albumin-binding contrast agent.
Circulation. 2012;126(6):707-719. 3.
Cornily JC, Hyafil F, Calcagno C, et al. Evaluation of neovessels in
atherosclerotic plaques of rabbits using an albumin-binding intravascular
contrast agent and MRI. J Magn Reson Imaging. 2008;27(6):1406-1411. 4. Hallström S, Gasser H, Neumayer C,
et al. S-nitroso human serum albumin treatment reduces ischemia/reperfusion
injury in skeletal muscle via nitric oxide release. Circulation. 2002;105(25):3032-3038.
5. Sourbron S, Ingrisch M, Siefert
A, et al. Quantification of cerebral blood flow, cerebral blood volume, and blood–brain-barrier
leakage with DCE-MRI. Magn Reson Med. 2009;62(1):205-217.